Comparative efficacy and safety of albuterol sulfate spiros inhaler and albuterol metered-dose inhaler in asthma

Chest

Volumn 115, Issue 2, 1999, Pages 329-335

  Nelson, Harold ^a   Kemp, James P ^b   Bieler, Stewart ^c   Vaughan, Leigh M ^c   Hill, Malcolm R ^c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^c Dura Pharmaceuticals   (United States)

Author keywords

Aerosol; Albuterol; Asthma; Bronchodilator; Dry powder inhaler

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032940311     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.2.329     Document Type: Article

References (22)

1. Barnes PJ. A new approach to the treatment of asthma. N Engl J Med 1989; 321:1517-1527
2. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol 1991; 88:425-534
3. Newhouse MT, Dolovich MB. Control of asthma by aerosols. N Engl J Med 1986; 315:870-874
4. Summer W, Elston R, Tharpe L, et al. Aerosol bronchodilator delivery methods. Arch Intern Med 1989; 149:618-623
5. Clark AR. Medical aerosol inhalers: past, present and future. Aerosol Sci Tech 1995; 22:374-391
6. Secretariat for the Vienna Convention for the Protection of the Ozone Layer and for the Montreal Protocol on Substances that Deplete the Ozone Layer. The Montreal Protocol on Substances That Deplete the Ozone Layer, Final Act. Nairobi, Kenya: United Nations Environment Programme, 1987
7. Hayman G. Why the environment matters. Br J Clin Pharmacol 1995; 79(suppl):2-61
8. Leach CL. Approaches and challenges to use of freon propellant replacements. Aerosol Sci Tech 1995; 22:328-334
9. Food and Drug Administration. Chlorofluorocarbon propellants in self-pressurizing containers: determinations that uses are no longer essential. Washington, DC: Food and Drug Administration, 1997:28
10. Shim C, Williams MH. The adequacy of inhalation of aerosol from canister nebulizers. Am J Med 1980; 69:891-894.
11. DeBlaquiere P, Christensen DB, Carter WB, et al. Use and misuse of metered-dose inhalers by patients with chronic lung disease. Am Rev Respir Dis 1989; 140:910-916
12. McFadden ER Jr. Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse. J Allergy Clin Immunol 1995; 96:278-283
13. Ogren RA, Baldwin JL, Simon RA. How patients determine when to replace their metered-dose inhalers. Ann Allergy 1995; 75:485-489
14. Pedersen S, Hansen OR, Fugslang G. Influence of inspiratory flow rate upon the effect of Turbuhaler. Arch Dis Child 1990; 65:308-311
15. Pedersen S. How to use a Rotahaler. Arch Dis Child 1986; 61:11-14
16. Newman SP, Moren F, Trofast E, et al. Terbutaline sulfate Turbuhaler: effect of inhaled flow rate on drug deposition and efficacy. Int J Pharm 1991; 74:209-213
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244
18. Pearlman DS, Chervinsky P, LaForce G, et al. A comparison of salmeterol with albuterol in the treatment of mild-moderate asthma. N Engl J Med 1992; 327:1420-1425
19. D'Alonzo GE, Nathan RA, Henochowicz S, et al. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994; 271:1412-1416
20. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia, PA: WB Saunders, 1971
21. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meets ATS recommendations. Am Rev Respir Dis 1981; 123:659-664
22. Repsher LH, Anderson JA, Bush RK, et al. Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol. Chest; 1984; 85:34-38